Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Praluent Injunction Goes Unmentioned At PCSK9 Patent Case Appeal

Jun 06 2017

• By Sue Sutter

court house

Related Content

Broad Enough? Sponsors Pleased With Narrower Praluent Label

Jul 24 2015

Praluent Fate Uncertain After Amgen Wins PCSK9 Patent Battle

Mar 17 2016

Roche Mircera Launch Blocked By Permanent Injunction

Oct 03 2008

‘Between A Rock And A Hard Place,’ Court Issues Injunction To Halt Praluent Sales

Jan 06 2017

Sanofi/Regeneron Get Reprieve: Praluent Can Stay On Market For Now

Feb 09 2017

Related Companies

Amgen, Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Pfizer Inc.

Eli Lilly and Company

Roche Holding AG

AbbVie Inc.

Additional Topics

United States Legal Issues Intellectual Property Biologics Policy Cardiovascular BioPharmaceutical

More from Legal & IP

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window